Recombinant plasmids coding for a soluble (or surface) antigen ofPasteurella haemolytica Al were identified. Two plasmids, both containing the same 5.4 kilobase pairs of insert DNA, were recovered independently by screening a clone bank of P. haemolytica Al genomic DNA in Escherichia coli for the expression of P. haemolytica Al soluble antigens (R. Y. C. Lo and L. A. Cameron, Can. J. Biochem. Cell Biol. 64:73-76, 1986). E. coli cells carrying the plasmids were found to be agglutinated by an antiserum raised against the P. haemolytica Al soluble antigens. Analysis of the E. coli clones by electron microscopy revealed patches of amorphous material on the surface of the cells which were not present on the controls. Further characterization with protein A-colloidal gold labeled both these patches and the outer membranes of these cloned cells pretreated with the specific antiserum. These results indicated that the cloned antigen was expressed on the surface of the E. coli cells. The cloned antigen was found to be specific for serotype 1 when tested by slide agglutination against a collection of P. haemolytica typing antisera. Southern blot hybridization, using the cloned DNA as a probe, labeled the genomic DNA from P. haemolytica serotype 1 as well as the cross-agglutinating serotypes 2 and 7, but not DNA from the non-cross-agglutinating serotypes 3 and 4 and PasteureUa multocida. These results demonstrated that serotype specificity could be attributed to the particular antigenic determinants in the genome of the organism.
Bovine pneumonic pasteurellosis, also known as shipping fever pneumonia; is the major cause of economic loss in the feedlot cattle industry in North America (26) . Pasteurella haemolytica is the principal organism isolated from pneumonic lungs, and although more than 12 serotypes of P. haemolytica are recognized, only type 1 (Al) and rarely type 2 are associated with this disease (2, 9, 25) . Serotypes are distinguished by differences in soluble or extractable surface antigens, using an indirect hemagglutination procedure (2) or a rapid plate agglutination test (10) . Serotype specificity is believed to reside in the polysaccharide capsular antigens (1, 7) , and vaccination with crude capsular extracts has been reported to protect calves against experimental infection (13, 27) , whereas vaccination with formalinized bacterins has been shown to be deleterious (12, 21) .
Vaccination of calves with live P. haemolytica Al or bacteria-free culture supernatant from logarithmic-phase cultures induces resistance to experimental challenge (4; P. E. Shewen and B. N. Wilkie, Abstr. Con. Res. Workers Anim. Dis. 1983 ). This culture supernatant contains a number of soluble substances including a ruminant-cell-specific leukotoxin, protease, neuraminidase, and soluble surface antigens shed during bacterial growth (22, 24) .
Vaccination with culture supernatant stimulates the production of serotype-specific agglutinating antibody and leukotoxin-neutralizing activity, both of which are apparently necessary for protection (Shewen and Wilkie, Abstr. Con. Res. Workers Anim. Dis. 1983). As an aid to understanding the relative role of each of the soluble antigens in protection, we attempted to separate these substances by molecular cloning. We recently reported the cloning of the leukotoxin gene of P. haemolytica among a collection of recombinant plasmids coding for the soluble antigens of P. haemolytica Al (18) . In this paper, we report the identification of recombinant plasmids coding for a serotype-specific antigen of P. haemolytica serotype 1. This cloned antigen from P. haemolytica Al was expressed and is located on the surface of Escherichia coli cells.
MATERIALS AND METHODS
Bacteria, plasmids, and culture conditions. E. coli HB101 and the construction of the clone bank of P. haemolytica Al genomic DNA were as described previously (17, 18) . Briefly, total genomic DNA from P. haemolytica Al was partially digested with Sau3A, and 5-to 10-kilobase pair (kbp) fragments were ligated into the BamHI site of the plasmid vector pBR322. After transformation into E. coli, recombinant plasmids were recovered by amplification in broth cultures for storage as the clone bank. P. haemolytica serotypes 1 to 12 were obtained from G. H. Frank, National Animal Disease Center, Ames, Iowa, who originally obtained them from E. L. Biberstein, University of California, Davis. Pasteurella multocida type A was isolated from a case of bovine pneumonia. The E. coli cultures were grown in LT medium supplemented with ampicillin (when appropriate) as described previously (17) , while P. haemolytica and P. multocida were cultured in brain heart infusion broth (Difco Laboratories, Detroit, Mich.).
Enzymes and chemicals. Restriction endonucleases and E. coli DNA polymerase I were purchased from Bethesda Research Laboratories (GIBCO, Burlington, Ontario, Canada) or Boehringer Mannheim (Dorval, Quebec, Canada) and used as described by the suppliers. The goat anti-rabbit immunoglobulin G-horseradish peroxidase conjugate and the horseradish peroxidase color development reagents were purchased from Bio-Rad Laboratories (Mississauga, Ontario, Canada). [a-32P]dATP (3, Immune dot-blot analysis of cloned antigen. The periplasmic proteins and cytoplasmic proteins from the E. coli clones were prepared as described previously (18) . The pellets from the 100,000 x g centrifugation step were suspended in 1 ml of 0.01 M Tris hydrochloride (pH 8) as the total membrane fractions. Protein concentrations were determined by the method of Lowry et al. (19) , and all samples were adjusted to a uniform protein content.
For the immune dot-blot assay, 2 j.! of each sample was spotted in quadruplicate onto nitrocellulose paper and allowed to dry. The nitrocellulose paper was immersed in a blocking solution (18) , followed by a first antibody solution containing the rabbit antiserum to the soluble antigens of P. haemolytica Al (1/100 dilution) and then a second antibody solution containing goat anti-rabbit immunoglobulin Ghorseradish peroxidase conjugate (1/2,000 dilution). The presence of the P. haemolytica antigen was detected with the horseradish peroxidase color development reagent.
Electron microscopy. E. coli HB101 carrying the recombinant plasmids was grown in broth culture to the optimal stage of antigen expression, harvested by centrifugation, and washed in 0.05 M HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (pH 6.8). The cells were suspended in anti-P. haemolytica type 1 serum diluted 1:10 in buffer for 15 min at 22°C and washed three times in buffer. These cells were then suspended in protein A-colloidal gold for 15 min in buffer and washed five times in buffer to remove unbound protein A-colloidal gold. The colloidal gold was prepared by the citrate method (6, 11) and was of uniform 25-nm size. Protein A was conjugated to the gold by the method of Romano and Romano (23) .
Whole mounts of cells treated with the specific antiserum and protein A-colloidal gold were made by floating a Formvar, carbon-coated, 200-mesh electron microscopy grid on a drop of the cell suspension for 30 s and then blotting it dry. The following controls were made in a similar manner: E. coli HB101 carrying the recombinant plasmids treated with (i) protein A-colloidal gold; (ii) the specific antiserum plus colloidal gold; (iii) a nonspecific antiserum (antiserum to E. coli 09 [BDH Chemicals]); (iv) the specific antiserum plus protein A; and (v) E. coli carrying pBR322 treated with the specific antiserum plus protein A-colloidal gold. When negative stains were necessary, grids with absorbed bacteria were floated on a drop of 2% ammonium molybdate (pH 6.8) for 15 s and blotted dry.
For thin sections, cells were treated with antiserum and protein A-colloidal gold as previously outlined. After washing, the cells were fixed in 5% glutaraldehyde in buffer for 1.5 h at 23°C, washed to remove unbound fixative, postfixed in 1% osmnium tetroxide in buffer for 2 h at 23°C, washed to remove soluble postfixative, ernrobed in 2% Noble agar, stained en bloc in 2% uranyl acetate for 2 h at 23°C, washed, dehydrated through an ethanol-propylene oxide series, and embedded in Epon 812. Thin sections were stained with uranyl acetate and lead citrate.
Ruthenium red (Polyscience, Warrington, Pa.) was used to stabilize acidic mucopolysaccharide in some fixations (20) . In these experiments the above conventional fixation regimen was used, except that 500 ,ug of ruthenium red per ml was incorporated into the glutaraldehyde and osmium tetroxide fixation solutions.
Electron microscopy was performed with a Philips EM300 electron microscope operating at 60 kV under standard conditions with the cold trap in place.
RESULTS
Expression of P. hiaernolytica antigen in recombinant clones. A collection of recombinant plasmids coding for the soluble antigens of P. haemolytica Al have been isolated in our laboratory from a genomic library of P. haemolytica Al DNA in the vector pBR322 (17) . Two recombinant clones, 32 and 38, were chosen for further characterization of the cloned antigen since both exhibited a very strong antigenic reaction in the initial screening experiments. Restriction endonuclease mapping of the two recombinant plasmids showed that both contained the same 5.4-kbp insert DNA (Fig. 1) Localization of cloned antigen in E. coli cells. Periplasmic proteins, cytoplasmic proteins, and total membrane preparations from the two clones were tested for the presence of P. haemolytica antigen by the immune dot-blot assay. Most of the antigenic substance was located in the membrane fraction of the E. coli clones, with a weak antigenic reaction in the cytoplasmic fraction ( Table 1 ). The antigenic reactions observed in all the periplasmic protein preparations were presumably due to E. coli proteins which cross-reacted with the antibody preparation and were not investigated further.
To determine whether the P. haemolytica antigen was exposed on the surface of the clones, we tested the E. coli cells by bacterial slide agglutination with the antiserum to the soluble antigens of P. haemolytica Al. The clones were agglutinated by this antiserum, whereas the control cells were not, thus indicating that the cloned antigen was expressed on the surface of the E. coli clones.
To further demonstrate the surface expression of the P. haemolytica antigen on the E. coli cells, we tested one of the clones for bacterial slide agglutination with antisera raised against E. coli surface antigens. The results (Table 2) show that there was good agglutination, as expected, with all the samples tested, with the exception that E. coli carrying pPH38 was not agglutinated with antiserum A. Antiserum A was raised against E. coli 09 and had been preabsorbed with 11 E. coli serotype 0 strains, while antiserum B was raised against E. coli 09:K30 and was not preabsorbed with E. coli whole cells. These results suggested that the cloned P. haemolytica antigen was present on the E. coli cell surface and was masking some of the E. coli surface antigens, thus preventing the agglutination reaction.
Expression of cloned antigen on the surface of E. coli. Whole mounts of E. coli cells carrying pPH32, when treated with specific antiserum followed by protein A-colloidal gold, were labeled by the gold probe (Fig. 2) . Since the 25-nm gold particle was much too large to penetrate the outer membrane, it was apparent that the cloned antigen was expressed on the surface. The labeling was a specific response to the antigen; all control samples showed negative or background gold particle counts which were not significant (Fig. 3) .
Thin sections of cloned cells which were treated with ruthenium red as a stain for acidic mucopolysaccharide (20) revealed small discrete patches of an amorphous matrix randomly distributed over the outer membrane surface which resembled capsular material. These were not seen in control cells. Conventional embeddings also revealed these patches, as did negative stains of whole mounts. These and the ruthenium red results suggested the matrix to be highly acidic and, possibly, composed of glycoprotein (15) . When the clones were pretreated with specific antiserum followed with protein A-colloidal gold, the outher membrane surface was decorated with the probe (Fig. 4) . Higher magnification demonstrated that the patches of material, previously demonstrated in thin section by ruthenium red and conventional treatments, were labeled by the gold (Fig.  5 ). In addition, select sites of the actual outer membrane surface were also labeled (Fig. 5) . Sometimes the label was observed adhering to small outer membrane vesicles with attached matrix which were sloughing off the cells (Fig. 6) ; this may represent the production of the soluble antigen which is found in the culture supernatant.
Serotype specificity of cloned antigen. Since the recombinant plasmids were originally isolated from a clone bank of DNA from P. haemolytica serotype 1, it was of interest to determine whether the cloned antigen was specific for serotype 1. Antisera specific for 12 serotypes of P. haemolytica were tested by bacterial slide agglutination for reactivity with P. haemolytica Al and E. coli carrying pBR322, pPH32, or pPH38 (Table 3 ). The results show that there is some nonspecific agglutination between all the typing sera and E. coli carrying pBR322 alone. This may be due to exposure of the rabbits to E. coli during preparation of the typing antisera. However, the nonspecific agglutination was not observed upon dilution of the antisera. This showed that the cloned antigen is specific for serotype 1 only. The higher specific agglutination of HB1O1(pPH32) [or HB101 (pPH38)] over P. haemolytica Al with the type 1-specific antiserum may be due to the presence of other surface materials on P. haemolytica Al which mask some of the agglutinating antigens or due to an elevated expression of the cloned antigen on the surface of E. coli.
Southern blot hybridization of cloned DNA. To demonstrate that the cloned DNA was of P. haemolytica origin, the 3.6-kbp HindIII fragment from the insert DNA of pPH32 was purified, nick translated with [32P]dATP, and used as a probe against P. haemolytica Al genomic DNA. The results (Fig.  7) demonstrated that the cloned DNA fragment hybridized to unique fragments of the P. haemolytica Al DNA digests.
In addition to the DNA from serotype 1 P. haemolytica, DNA from several other serotypes as well as P. multocida was also probed with the cloned DNA insert. The results showed that the cloned DNA hybridized weakly to DNA from serotypes 2 and 7, but not to DNA from serotypes 3 and 4 ( Fig. 7) . Furthermore, there was no hybridization to DNA from P. multocida. These results indicated that serotype specificity could be attributed to particular antigenic determinants carried on the DNA molecule. 
DISCUSSION
When the different cellular components (i.e., cytoplasmic proteins, periplasmic proteins, and the membrane fractions) from E. coli cells carrying pPH32 or pPH38 were examined by the immune dot-blot assay, a strong antigenic response was observed with the membrane fractions. This suggested that the P. haemolytica antigen(s) expressed from pPH32 or pPH38 was associated with the membranes of the E. coli cells. This was supported by bacterial slide agglutination tests which showed that E. coli cells carrying pPH32 or pPH38 could be agglutinated with an antiserum raised against the soluble antigens of P. haemolytica Al. Furthermore, the cloned P. haemolytica antigen appeared to mask some of the E. coli surface antigens, as indicated by the loss of agglutination of E. coli(pPH38) with the anti-E. coli 09 lipopolysaccharide antiserum.
Further evidence for the surface localization of the cloned P. haemolytica antigen on the E. coli cells was provided by examining the cell surface by electron microscopy. Both negative stains and thin sections revealed patches of an amorphous matrix similar to capsular material on the cells carrying pPH32. These were not found on E. coli(pBR322) control samples. In addition, protein A-collodial gold treatment labeled this material as well as a surface component. It is quite possible that it was this amorphous material that was masking a proportion of the 09 lipopolysaccharide antigen during our agglutination studies. Furthermore, electron microscopy demonstrated that the gold particles also labeled the actual outer membrane surface and that the blebbing and sloughing off of this material could account for the soluble antigen found in the culture supernatants. Clearly, these results give tangible evidence of an outer membrane surface location for the antigen and of the secretion from the cloned cells of an unusual polymeric substance (the amorphous surface matrix) which is antigenic.
The recombinant plasmids were initially isolated by screening for the expression of P. (8, 16) . Since the antiserum used in the initial screening experiment was raised against serotype 1 soluble antigens, it is probable that soluble antigens may also be involved in determining serotype specificity for this bacterium. Further experiments are being conducted to determine the nature of this cloned antigen and its relationship to the P. haemolytica cell surface. In addition, the importance of P. haemolytica serotype 1 as the primary organism associated with bovine pneumonia A-colloidal gold labeling. Note that the gold on the cell is equal to, or less than, the background gold levels on the support film. This is representative of all controls. 4. Thin section of a cloned cell treated as in Fig. 2 . The arrows point to the gold probe. 5. Higher magnification of the gold probe-outer membrane interaction. Two gold particles label the patches of amorphous matrix on the cell surface (small arrows point to matrix), whereas two particles are attached directly to the outer membrane surface (large arrow). The grey halo surrounding each gold particle is the conjugated protein A. 6. Two gold particles adsorbed to a small vesicle of outer membrane which has detached from the cell surface. The arrow points to the patch of matrix adhering to the vesicle.
VOL. 53, 1986 on October 19, 2017 by guest http://iai.asm.org/ Downloaded from makes relevant the determination of the role of this cloned antigen in the pathogenicity of serotype 1 in cattle. The immunogenicity of the cloned antigen is being evaluated in rabbits to determine its possible use in stimulating an immune response against P. haemolytica Al in cattle.
Southern blot hybridization of the cloned DNA against genomic DNA from several serotypes of P. haemolytica showed that the cloned DNA hybridized strongly to genomic DNA from serotype 1 and weakly to DNA from serotypes 2 and 7. There was some degree of serotype cross-reactivity between serotype 1 and serotypes 2 and 7 ( Table 3) . The hybridization results indicated that this cross-reactivity is a reflection of the DNA sequence coding for the particular antigenic determinant. Serotypes 3 and 4 do not cross-react with serotype 1, and there is no DNA hybridization with the cloned DNA. This demonstrates that serotype specificities are phenotypic manifestations of the different antigenic determinants carried in the DNA molecule. The lack of hybridization between the cloned DNA and DNA from P. multocida further supports these interpretations.
In conclusion, we identified recombinant plasmids coding for a particular serotype-specific antigen of P. haemolytica Al. The cloned antigen was expressed and located on the surface of E. coli cells. The study of such a cloned antigen permits further analysis of the surface structure of P. haemolytica as well as the components involved in the pathogenicity of serotype 1. We are currently characterizing the other recombinant plasmids isolated from the same screening experiments to identify additional surface or soluble antigens from P. haemolytica Al.
